Stocks | |||||
The table gives an overview of all stocks, alphabetically sorted. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Name | Symbol | Analysis date | Close | +/- % |
Telephone And Data Systems | TDS | Nov 15, 2024 | 31.17 | +1.76 |
Telephone And Data Systems Pref | TDS-U | Nov 15, 2024 | 21.58 | -0.14 |
Telephone And Data Systems VV Pref | TDS-V | Nov 15, 2024 | 19.27 | -0.16 |
Telesat | TSAT | Nov 15, 2024 | 11.99 | -9.24 |
Telomir Pharmaceuticals | TELO | Nov 15, 2024 | 3.73 | -5.81 |
Telos | TLS | Nov 15, 2024 | 3.30 | -5.71 |
Telus | TU | Nov 15, 2024 | 15.17 | -0.07 |
Telus International | TIXT | Nov 15, 2024 | 3.62 | -6.46 |
Tempest Therapeutics | TPST | Nov 15, 2024 | 0.89 | -8.27 |
Templeton Dragon Fund | TDF | Nov 15, 2024 | 8.58 | -0.46 |
Templeton Emerging Markets | TEI | Nov 15, 2024 | 5.34 | -0.19 |
Templeton Emerging Markets Fund | EMF | Nov 15, 2024 | 12.64 | +0.40 |
Tempur Sealy International | TPX | Nov 15, 2024 | 54.14 | -1.42 |
Tempus AI | TEM | Nov 15, 2024 | 52.40 | -7.47 |
Tenable | TENB | Nov 15, 2024 | 40.79 | -2.28 |
Tenaris ADR | TS | Nov 15, 2024 | 37.00 | +0.11 |
Tenax Therapeutics | TENX | Nov 15, 2024 | 4.87 | -1.42 |
Tenaya Therapeutics | TNYA | Nov 15, 2024 | 1.97 | -2.48 |
Tencent Music Entertainment A ADR | TME | Nov 15, 2024 | 11.07 | +2.41 |
Tenet Healthcare | THC | Nov 15, 2024 | 155.34 | -4.49 |
Tennant | TNC | Nov 15, 2024 | 86.23 | -1.10 |
Tennessee Valley Authority C Pref | TVC | Nov 15, 2024 | 22.86 | 0.00 |
Tennessee Valley Authority E Pref | TVE | Nov 15, 2024 | 22.38 | +0.18 |
Tenon Medical | TNON | Nov 15, 2024 | 2.71 | -3.56 |
Teradata | TDC | Nov 15, 2024 | 28.97 | -2.10 |
Teradyne | TER | Nov 15, 2024 | 102.58 | -3.70 |
TeraWulf | WULF | Nov 15, 2024 | 7.18 | +3.38 |
Terex | TEX | Nov 15, 2024 | 51.98 | -1.12 |
Ternium ADR | TX | Nov 15, 2024 | 34.19 | +2.30 |
Terns Pharmaceuticals | TERN | Nov 15, 2024 | 6.17 | -5.80 |
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.